Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 11;15(7):1928.
doi: 10.3390/pharmaceutics15071928.

Research Progress on Stimulus-Responsive Polymer Nanocarriers for Cancer Treatment

Affiliations
Review

Research Progress on Stimulus-Responsive Polymer Nanocarriers for Cancer Treatment

Shicui Luo et al. Pharmaceutics. .

Abstract

As drug carriers for cancer treatment, stimulus-responsive polymer nanomaterials are a major research focus. These nanocarriers respond to specific stimulus signals (e.g., pH, redox, hypoxia, enzymes, temperature, and light) to precisely control drug release, thereby improving drug uptake rates in cancer cells and reducing drug damage to normal cells. Therefore, we reviewed the research progress in the past 6 years and the mechanisms underpinning single and multiple stimulus-responsive polymer nanocarriers in tumour therapy. The advantages and disadvantages of various stimulus-responsive polymeric nanomaterials are summarised, and the future outlook is provided to provide a scientific and theoretical rationale for further research, development, and utilisation of stimulus-responsive nanocarriers.

Keywords: cancer; carrier; polymer nanomaterials; stimulus-responsive.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Scheme 1
Scheme 1
Targeted delivery strategies and polymer micelle mechanisms. Reprinted with permission from [32]. Copyright 2019, Elsevier.
Scheme 2
Scheme 2
HA-DOX/PHIS/R848 NP preparation (A) and functional mechanisms during breast cancer treatment (B). Reprinted with permission from [39]. Copyright 2018, Elsevier.
Scheme 3
Scheme 3
Illustration diagram of the preparation of dual-responsive PCL-SS@DTX NPs and the DTX release triggered by ROS and GSH for orthotopic prostate cancer therapy in vivo. Reprinted with permission from [77]. Copyright 2021, Elsevier.
Scheme 4
Scheme 4
Schematic diagram of the action of the enzyme-stimulated responsive nanocarrier carrier. Reprinted with permission from [82]. Copyright 2019, Elsevier.
Scheme 5
Scheme 5
Nanoparticle (PAPNP) preparation and functional mechanisms in tumour hypoxic-specific drug release and anti-tumour activity. The number of bombs in the graph indicates the anti-tumour effect in vitro, the higher the number of bombs, the better the anti-tumour effect. Reprinted with permission from [98]. Copyright 2018, 2022 American Chemical Society.
Scheme 6
Scheme 6
Preparation process of polymeric micelles (GA@PEG-TK-ICG PM) and some of the processes that occur in vivo in response to stimulation. Reprinted with permission from [150]. Copyright 2021, Elsevier.

Similar articles

Cited by

References

    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Jia X., Zhang Y., Zou Y., Wang Y., Niu D., He Q., Huang Z., Zhu W., Tian H., Shi J. Dual intratumoral redox/enzyme-responsive NO-releasing nanomedicine for the specific, high-efficacy, and low-toxic cancer therapy. Adv. Mater. 2018;30:1704490. doi: 10.1002/adma.201704490. - DOI - PubMed
    1. Goyal A.K., Rath G., Faujdar C., Malik B. Applications of Targeted Nano Drugs and Delivery Systems. Elsevier; Amsterdam, The Netherlands: 2019. Application and Perspective of pH-Responsive Nano Drug Delivery Systems; pp. 15–33.
    1. Seah I., Ong C., Liu Z., Su X. Polymeric biomaterials in the treatment of posterior segment diseases. Front. Med. 2022;9:949543. doi: 10.3389/fmed.2022.949543. - DOI - PMC - PubMed
    1. Solanki R., Rostamabadi H., Patel S., Jafari S.M. Anticancer nano-delivery systems based on bovine serum albumin nanoparticles: A critical review. Int. J. Biol. Macromol. 2021;193:528–540. doi: 10.1016/j.ijbiomac.2021.10.040. - DOI - PubMed